Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIV Reservoir Reduction With Interleukin-2
NCT03308786Phase 2Terminated
- Sponsor
- Case Western Reserve University
- Start
- Apr 2019
- Primary completion
- Aug 2020
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in human immunodeficiency virus infection (HIV), sponsored by Case Western Reserve University. Started Apr 2019; status: terminated.
02
Drugs
aldesleukin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03308786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03308786.